A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib.
| Image |  |
|---|---|
| Description | scientific article published on 21 December 2014 |
| Author/s |
author: Bryan T. Hennessy Sinead Toomey Naomi Elster Alex J. Eustace |
| Publication date | December 21, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |